What Happened?
Shares of life sciences company Thermo Fisher (NYSE: TMO) jumped 9.7% in the afternoon session after the company reported strong second-quarter earnings that beat Wall Street's estimates for both profit and revenue. For the quarter, the company reported adjusted earnings per share of $6.03, topping expectations of $5.71. Revenue came in at $11.99 billion, a 10.5% year-over-year increase that surpassed Wall Street's forecasts of $11.72 billion. Organic revenue also grew by 5% year on year. Furthermore, the company demonstrated robust cash generation, with its free cash flow margin expanding to 14%, up from 10.2% in the same quarter last year. Overall, it was a solid quarter for Thermo Fisher, highlighting strong top-line performance that exceeded analysts' expectations.
Is now the time to buy Thermo Fisher? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Thermo Fisher’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was about 1 year ago when the stock gained 12.3% on the news that the company reported second-quarter earnings and revenue that surpassed Wall Street estimates and raised its full-year financial guidance. The company posted adjusted earnings per share (EPS) of $5.36 on revenue of $10.85 billion. These results topped the average analyst estimates, which had projected an EPS of $5.22 on revenue of $10.65 billion. EPS is a widely used metric of a company's profitability. Following the strong quarterly performance, Thermo Fisher lifted its outlook for the full year. The company now expected 2025 revenue to be between $43.6 billion and $44.2 billion, raising the lower end of its previous forecast. It also increased its adjusted EPS guidance to a range of $22.22 to $22.84. The better-than-expected results were driven by growth in its Life Sciences Solutions and Lab Products & Biopharma Services divisions.
Thermo Fisher is down 3.6% since the beginning of the year, and at $571.39 per share, it is trading 10.6% below its 52-week high of $639.45 from January 2026. Despite the year-to-date decline, investors who bought $1,000 worth of Thermo Fisher’s shares 5 years ago would now be looking at an investment worth $1,074.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
